EKTAF (Elekta AB) Current Deferred Revenue : $0 Mil (As of Jul. 2024)

View and export this data going back to . Start your Free Trial

What is Elekta AB Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Elekta AB's current deferred revenue for the quarter that ended in Jul. 2024 was $0 Mil.

Elekta AB Current Deferred Revenue Historical Data

The historical data trend for Elekta AB's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Current Deferred Revenue Chart

Elekta AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Current Deferred Revenue

Get a 7-Day Free Trial

Elekta AB Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Elekta AB Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Elekta AB's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Elekta AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAF) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

EKTAY:USA EKTA B:Sweden EKTAB:Mexico EKTABs:UK 0O5H:UK EJXB:Germany

Address

Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93

Website

https://www.elekta.com

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.